share_log

啓明醫療-B：截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

VENUS MEDTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024

香港交易所 ·  Mar 5 03:57
Summary by Moomoo AI
杭州啓明醫療器械股份有限公司（啓明医疗-B）於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的股份變動情況。報告顯示，公司的普通股H類股份（股份代號02500）在香港聯交所上市的法定/註冊股本結存維持不變，為441,010,235股，每股面值1人民幣。此外，非上市外資股的結存亦維持在1,208股。公司的股份期權計劃於2023年7月12日獲股東大會通過，本月內沒有股份期權的變動，結存數目為0，但根據計劃，公司最多可發行44,101,023股新股份。報告中未提及其他類別的股份變動，並確認所有相關法律文件已正式存檔，所有條件已履行。
杭州啓明醫療器械股份有限公司（啓明医疗-B）於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的股份變動情況。報告顯示，公司的普通股H類股份（股份代號02500）在香港聯交所上市的法定/註冊股本結存維持不變，為441,010,235股，每股面值1人民幣。此外，非上市外資股的結存亦維持在1,208股。公司的股份期權計劃於2023年7月12日獲股東大會通過，本月內沒有股份期權的變動，結存數目為0，但根據計劃，公司最多可發行44,101,023股新股份。報告中未提及其他類別的股份變動，並確認所有相關法律文件已正式存檔，所有條件已履行。
HANGZHOU KAIMING MEDICAL DEVICES CO., LTD. (KAIMING MEDICAL-B) FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 5, 2024, REPORTING THE STOCK CHANGES AS OF FEBRUARY 29, 2024. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED CAPITAL OF THE COMPANY'S ORDINARY CLASS H SHARES (SHARE CODE 02500) LISTED ON THE HONG KONG EXCHANGE REMAINED UNCHANGED AT 441,010,235 SHARES WITH AN EQUIVALENT VALUE OF RMB 1 PER SHARE. In addition, the cash flow of non-listed foreign stocks remained at 1,208 shares. The Company's stock option plan was approved by the General Meeting on July 12, 2023. No change in share options during the month and the number of deposits is 0, but according to the plan, the company may issue a maximum of 44,101,023 new shares. The report does not mention changes in other categories of shares and confirms that all relevant legal documents have been formally filed and all conditions have been met.
HANGZHOU KAIMING MEDICAL DEVICES CO., LTD. (KAIMING MEDICAL-B) FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 5, 2024, REPORTING THE STOCK CHANGES AS OF FEBRUARY 29, 2024. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED CAPITAL OF THE COMPANY'S ORDINARY CLASS H SHARES (SHARE CODE 02500) LISTED ON THE HONG KONG EXCHANGE REMAINED UNCHANGED AT 441,010,235 SHARES WITH AN EQUIVALENT VALUE OF RMB 1 PER SHARE. In addition, the cash flow of non-listed foreign stocks remained at 1,208 shares. The Company's stock option plan was approved by the General Meeting on July 12, 2023. No change in share options during the month and the number of deposits is 0, but according to the plan, the company may issue a maximum of 44,101,023 new shares. The report does not mention changes in other categories of shares and confirms that all relevant legal documents have been formally filed and all conditions have been met.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more